Literature DB >> 29476790

Oncogene-induced regulation of microRNA expression: Implications for cancer initiation, progression and therapy.

Athanasios R Paliouras1, Tiziana Monteverde1, Michela Garofalo2.   

Abstract

A plethora of tumours have characteristic oncogenic mutations which are the main causes of malignant transformation, exerting their effects through multiple signalling pathways. Downstream of such pathways, microRNAs are small non-coding RNAs that negatively regulate gene expression, assisting or antagonizing oncogenic signalling. The differential expression of microRNAs in cancer is well-documented and is considered a fundamental aspect of tumourigenesis. While data mapping the interaction between oncogenic lesions and microRNAs are accruing, we provide particular cases of such interaction. Except for notable, well-studied examples of microRNAs regulated by oncogenes, we examine the effect of this relationship in regard to tumour initiation, progression, metastasis and ultimately, its implications for the development of new therapeutics.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MiRNA therapeutics; MicroRNA; MicroRNA regulation; Oncogene addiction; Tumour initiation; Tumour progression

Mesh:

Substances:

Year:  2018        PMID: 29476790     DOI: 10.1016/j.canlet.2018.02.029

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.

Authors:  Yu Li; Huibiao Zhang; Lei Fan; Jiahui Mou; Yue Yin; Chao Peng; Yuxiang Chen; Henglei Lu; Liting Zhao; Zhouteng Tao; Jing Chen; Yizheng Wang; Xinming Qi; Ruimin Huang; Jin Ren
Journal:  Oncogene       Date:  2020-02-27       Impact factor: 9.867

2.  miR-665 is downregulated in glioma and inhibits tumor cell proliferation, migration and invasion by targeting high mobility group box 1.

Authors:  Hao Shen; Ling Xu; Chunyue You; Huaibo Tang; Haitao Wu; Yong Zhang; Mingxiang Xie
Journal:  Oncol Lett       Date:  2020-12-31       Impact factor: 2.967

3.  miR-448 promotes progression of non-small-cell lung cancer via targeting SIRT1.

Authors:  Hongfeng Qi; Haifeng Wang; Dabin Pang
Journal:  Exp Ther Med       Date:  2019-07-05       Impact factor: 2.447

4.  MicroRNA‑542‑3p represses OTUB1 expression to inhibit migration and invasion of esophageal cancer cells.

Authors:  Jun Sun; Yong Deng; Jin Shi; Wengang Yang
Journal:  Mol Med Rep       Date:  2019-11-20       Impact factor: 2.952

5.  Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo.

Authors:  Tingting Shi; Jian Gong; Koji Fujita; Noriko Nishiyama; Hisakazu Iwama; Shi Liu; Mai Nakahara; Hirohito Yoneyama; Asahiro Morishita; Takako Nonura; Hideki Kobara; Keiichi Okano; Yasuyuki Suzuki; Tsutomu Masaki
Journal:  Int J Oncol       Date:  2020-12-30       Impact factor: 5.650

Review 6.  A review on interplay between small RNAs and oxidative stress in cancer progression.

Authors:  Aparimita Das; Harsha Ganesan; Sushmitha Sriramulu; Francesco Marotta; N R Rajesh Kanna; Antara Banerjee; Fang He; Asim K Duttaroy; Surajit Pathak
Journal:  Mol Cell Biochem       Date:  2021-07-22       Impact factor: 3.396

7.  Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer.

Authors:  Yoshihisa Tokumaru; Masanori Oshi; Michelle R Huyser; Li Yan; Masahiro Fukada; Nobuhisa Matsuhashi; Manabu Futamura; Yukihiro Akao; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

Review 8.  Interactions between the MicroRNAs and Microbiota in Cancer Development: Roles and Therapeutic Opportunities.

Authors:  Alessandro Allegra; Caterina Musolino; Alessandro Tonacci; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Cancers (Basel)       Date:  2020-03-27       Impact factor: 6.639

9.  miR-491-5p inhibits the proliferation and migration of A549 cells by FOXP4.

Authors:  Fuyong Wu; Aiping Ji; Zhenkun Zhang; Jinfang Li; Penglong Li
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

10.  miRNome and Functional Network Analysis of PGRMC1 Regulated miRNA Target Genes Identify Pathways and Biological Functions Associated With Triple Negative Breast Cancer.

Authors:  Diego A Pedroza; Matthew Ramirez; Venkatesh Rajamanickam; Ramadevi Subramani; Victoria Margolis; Tugba Gurbuz; Adriana Estrada; Rajkumar Lakshmanaswamy
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.